ストックスクリーナーアプリを入手
88.54
0.17%
0.15
アフターアワーズ：
89.74
1.20
+1.36%
前日終値:
$88.39
開ける：
$88.405
24時間の取引高:
1.60M
Relative Volume:
1.37
時価総額：
$11.04B
収益：
-
当期純損益:
$-507.65M
株価収益率:
-22.84
EPS:
-3.876
ネットキャッシュフロー:
$-616.24M
1週間 パフォーマンス:
+1.97%
1か月 パフォーマンス:
-21.41%
6か月 パフォーマンス:
+24.08%
1年 パフォーマンス:
+80.69%
1日の値動き範囲:
$87.94
$91.32
1週間の範囲:
$84.52
$92.87
52週間の値動き範囲:
$48.24
$121.06
Vaxcyte Inc Stock (PCVX) Company Profile
名前
Vaxcyte Inc
セクター
電話
650-837-0111
住所
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
PCVX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| PCVX | 88.54 | 11.04B | 0 | -507.65M | -616.24M | -3.876 |
| VRTX | 450.97 | 116.14B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 738.00 | 81.10B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 605.92 | 36.23B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 244.89 | 31.59B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 113.13 | 27.12B | 3.30B | -501.07M | 1.03B | 11.54 |
Vaxcyte Inc Stock (PCVX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-12-07 | 開始されました | Mizuho | Buy |
| 2023-04-18 | 開始されました | TD Cowen | Outperform |
| 2023-01-03 | 繰り返されました | Needham | Buy |
| 2022-12-15 | 開始されました | Guggenheim | Buy |
| 2022-11-17 | 開始されました | BTIG Research | Buy |
| 2021-12-29 | 再開されました | Jefferies | Buy |
| 2021-06-24 | 再開されました | Jefferies | Buy |
| 2020-07-07 | 開始されました | BofA Securities | Buy |
| 2020-07-07 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-07-07 | 開始されました | Needham | Buy |
すべてを表示
Vaxcyte Inc (PCVX) 最新ニュース
Eagle Asset Management Inc. Trims Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) Shares Purchased by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
B. Metzler seel. Sohn & Co. Holding AG Invests $1.19 Million in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte expands headquarters with new lease agreement By Investing.com - Investing.com Canada
Vaxcyte expands headquarters with new lease agreement - Investing.com India
Vaxcyte Signs Extension, Expansion at Alexandria Campus in San Carlos - Connect CRE
Alexandria Real Estate Signs Major 10-Year Lease with Vaxcyte at San Carlos Campus | ARE Stock News - StockTitan
Vaxcyte, Inc. (NASDAQ:PCVX) Shares Sold by Segall Bryant & Hamill LLC - MarketBeat
Principal Financial Group Inc. Buys 34,287 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Jennison Associates LLC Decreases Stake in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) is First Turn Management LLC's 5th Largest Position - MarketBeat
Victory Capital Management Inc. Has $29.14 Million Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Curi RMB Capital LLC Invests $903,000 in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Los Angeles Capital Management LLC Purchases New Stake in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte (NASDAQ:PCVX) Sees Large Volume IncreaseStill a Buy? - MarketBeat
RA Capital Management, L.P. Increases Stake in Vaxcyte Inc - GuruFocus.com
Janus Henderson Group PLC's Strategic Acquisition of Vaxcyte Inc Shares - GuruFocus.com
Long Term Trading Analysis for (PCVX) - Stock Traders Daily
Vaxcyte Enters Oversold Territory (PCVX) - Nasdaq
FMR LLC Adjusts Stake in Vaxcyte Inc - GuruFocus.com
Vaxcyte provides regulatory updates on VAX-31 programs - TipRanks
FDA advances Vaxcyte's pneumococcal vaccine VAX-31 By Investing.com - Investing.com Canada
FDA advances Vaxcyte's pneumococcal vaccine VAX-31 - Investing.com
Vaxcyte Provides Positive Regulatory Updates on VAX-31 Pediatric and Adult Programs - The Bakersfield Californian
Vaxcyte's VAX-31 Vaccine Secures FDA Breakthrough Status, Targets 95% Disease Coverage | PCVX Stock News - StockTitan
WCM Investment Management LLC Has $15.94 Million Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Lisanti Capital Growth LLC Purchases 13,175 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Cantor Fitzgerald Increases Earnings Estimates for Vaxcyte - MarketBeat
TimesSquare Capital Management LLC Buys New Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) CEO Sells $245,803.74 in Stock - MarketBeat
Vaxcyte CEO Grant Pickering sells $245,796 in company stock - Investing.com India
Vaxcyte CEO Grant Pickering sells $245,796 in company stock By Investing.com - Investing.com Australia
FY2024 EPS Estimates for Vaxcyte Raised by Leerink Partnrs - MarketBeat
We're Hopeful That Vaxcyte (NASDAQ:PCVX) Will Use Its Cash Wisely - Yahoo Finance
Vaxcyte, Inc. Navigates AI Risks Amidst Regulatory and Ethical Challenges - TipRanks
Vaxcyte's (PCVX) Overweight Rating Reaffirmed at Cantor Fitzgerald - MarketBeat
Vaxcyte's (PCVX) "Buy" Rating Reiterated at Needham & Company LLC - MarketBeat
Vaxcyte stock target lifted as analyst sees VAX-31 leading in clinical advancement - Investing.com UK
Leerink Partners reaffirms Outperform on Vaxcyte stock with bullish pipeline outlook - Investing.com UK
Decoding Vaxcyte Inc (PCVX): A Strategic SWOT Insight - GuruFocus.com
Vaxcyte Reports Progress and Strengthens Financial Position - TipRanks
Vaxcyte Inc (PCVX) Reports Q3 2024 Net Loss of $103.1 Million Am - GuruFocus.com
Vaxcyte Reports Third Quarter 2024 Financial Results and Provides Business Update - The Manila Times
Vaxcyte's VAX-31 Vaccine Shows Promise in Phase 1/2, Plans Phase 3 Amid $3.3B Cash Position | PCVX Stock News - StockTitan
Vaxcyte, Inc. (NASDAQ:PCVX) COO Jim Wassil Sells 8,000 Shares - MarketBeat
Vaxcyte CEO Grant Pickering sells shares worth $1.6 million By Investing.com - Investing.com Australia
Vaxcyte COO Jim Wassil sells $854k in stock - Investing.com
Vaxcyte CEO Grant Pickering sells shares worth $1.6 million - Investing.com
Vaxcyte COO Jim Wassil sells $854k in stock By Investing.com - Investing.com UK
Harbor Capital Advisors Inc. Has $7.39 Million Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte Inc (PCVX) 財務データ
収益
当期純利益
現金流量
EPS
1.89%
2.08%
大文字化:
|
ボリューム (24 時間):